img

Global Antihypertensive Agents Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antihypertensive Agents Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Antihypertensive Agents Market
The global Antihypertensive Agents market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antihypertensive Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Antihypertensive Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Antihypertensive Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Antihypertensive Agents include Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals, Bayer, Johnson & Johnson, Sun Pharmaceutical Industries, Merck and AstraZeneca, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Antihypertensive Agents market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Antihypertensive Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antihypertensive Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antihypertensive Agents revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Antihypertensive Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Antihypertensive Agents revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals, Bayer, Johnson & Johnson, Sun Pharmaceutical Industries, Merck and AstraZeneca, etc.



By Company


Baxter International
Pfizer
Sandoz
Teva Pharmaceuticals
Bayer
Johnson & Johnson
Sun Pharmaceutical Industries
Merck
AstraZeneca
Daiichi Sankyo
Takeda
Actelion
Viatris
United Therapeutics
Lupin Limited
Hikma Pharmaceuticals
Aurobindo Pharma
Camber Pharmaceutical
Major Pharmaceuticals
Glenmark Pharmaceuticals
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Endo International
Unichem Laboratories
Huahai Pharmaceutical
Shijiazhuang Pharma Group
Shanghai Shyndec Pharmaceutical
Segment by Type
Thiazide Diuretics
Calcium Channel Blockers (CCB)
ACE Inhibitors
Angiotensin II Receptor Antagonists (ARBs)

Segment by Application


Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Antihypertensive Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Antihypertensive Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihypertensive Agents revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihypertensive Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Thiazide Diuretics
1.2.3 Calcium Channel Blockers (CCB)
1.2.4 ACE Inhibitors
1.2.5 Angiotensin II Receptor Antagonists (ARBs)
1.3 Market by Application
1.3.1 Global Antihypertensive Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihypertensive Agents Market Perspective (2018-2034)
2.2 Global Antihypertensive Agents Growth Trends by Region
2.2.1 Antihypertensive Agents Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Antihypertensive Agents Historic Market Size by Region (2018-2024)
2.2.3 Antihypertensive Agents Forecasted Market Size by Region (2024-2034)
2.3 Antihypertensive Agents Market Dynamics
2.3.1 Antihypertensive Agents Industry Trends
2.3.2 Antihypertensive Agents Market Drivers
2.3.3 Antihypertensive Agents Market Challenges
2.3.4 Antihypertensive Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antihypertensive Agents by Players
3.1.1 Global Antihypertensive Agents Revenue by Players (2018-2024)
3.1.2 Global Antihypertensive Agents Revenue Market Share by Players (2018-2024)
3.2 Global Antihypertensive Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antihypertensive Agents, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Antihypertensive Agents Market Concentration Ratio
3.4.1 Global Antihypertensive Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihypertensive Agents Revenue in 2022
3.5 Global Key Players of Antihypertensive Agents Head office and Area Served
3.6 Global Key Players of Antihypertensive Agents, Product and Application
3.7 Global Key Players of Antihypertensive Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antihypertensive Agents Breakdown Data by Type
4.1 Global Antihypertensive Agents Historic Market Size by Type (2018-2024)
4.2 Global Antihypertensive Agents Forecasted Market Size by Type (2024-2034)
5 Antihypertensive Agents Breakdown Data by Application
5.1 Global Antihypertensive Agents Historic Market Size by Application (2018-2024)
5.2 Global Antihypertensive Agents Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antihypertensive Agents Market Size (2018-2034)
6.2 North America Antihypertensive Agents Market Size by Type
6.2.1 North America Antihypertensive Agents Market Size by Type (2018-2024)
6.2.2 North America Antihypertensive Agents Market Size by Type (2024-2034)
6.2.3 North America Antihypertensive Agents Market Share by Type (2018-2034)
6.3 North America Antihypertensive Agents Market Size by Application
6.3.1 North America Antihypertensive Agents Market Size by Application (2018-2024)
6.3.2 North America Antihypertensive Agents Market Size by Application (2024-2034)
6.3.3 North America Antihypertensive Agents Market Share by Application (2018-2034)
6.4 North America Antihypertensive Agents Market Size by Country
6.4.1 North America Antihypertensive Agents Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Antihypertensive Agents Market Size by Country (2018-2024)
6.4.3 North America Antihypertensive Agents Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Antihypertensive Agents Market Size (2018-2034)
7.2 Europe Antihypertensive Agents Market Size by Type
7.2.1 Europe Antihypertensive Agents Market Size by Type (2018-2024)
7.2.2 Europe Antihypertensive Agents Market Size by Type (2024-2034)
7.2.3 Europe Antihypertensive Agents Market Share by Type (2018-2034)
7.3 Europe Antihypertensive Agents Market Size by Application
7.3.1 Europe Antihypertensive Agents Market Size by Application (2018-2024)
7.3.2 Europe Antihypertensive Agents Market Size by Application (2024-2034)
7.3.3 Europe Antihypertensive Agents Market Share by Application (2018-2034)
7.4 Europe Antihypertensive Agents Market Size by Country
7.4.1 Europe Antihypertensive Agents Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Antihypertensive Agents Market Size by Country (2018-2024)
7.4.3 Europe Antihypertensive Agents Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antihypertensive Agents Market Size (2018-2034)
8.2 China Antihypertensive Agents Market Size by Type
8.2.1 China Antihypertensive Agents Market Size by Type (2018-2024)
8.2.2 China Antihypertensive Agents Market Size by Type (2024-2034)
8.2.3 China Antihypertensive Agents Market Share by Type (2018-2034)
8.3 China Antihypertensive Agents Market Size by Application
8.3.1 China Antihypertensive Agents Market Size by Application (2018-2024)
8.3.2 China Antihypertensive Agents Market Size by Application (2024-2034)
8.3.3 China Antihypertensive Agents Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Antihypertensive Agents Market Size (2018-2034)
9.2 Asia Antihypertensive Agents Market Size by Type
9.2.1 Asia Antihypertensive Agents Market Size by Type (2018-2024)
9.2.2 Asia Antihypertensive Agents Market Size by Type (2024-2034)
9.2.3 Asia Antihypertensive Agents Market Share by Type (2018-2034)
9.3 Asia Antihypertensive Agents Market Size by Application
9.3.1 Asia Antihypertensive Agents Market Size by Application (2018-2024)
9.3.2 Asia Antihypertensive Agents Market Size by Application (2024-2034)
9.3.3 Asia Antihypertensive Agents Market Share by Application (2018-2034)
9.4 Asia Antihypertensive Agents Market Size by Region
9.4.1 Asia Antihypertensive Agents Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Antihypertensive Agents Market Size by Region (2018-2024)
9.4.3 Asia Antihypertensive Agents Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antihypertensive Agents Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Antihypertensive Agents Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Antihypertensive Agents Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Baxter International
11.1.1 Baxter International Company Details
11.1.2 Baxter International Business Overview
11.1.3 Baxter International Antihypertensive Agents Introduction
11.1.4 Baxter International Revenue in Antihypertensive Agents Business (2018-2024)
11.1.5 Baxter International Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Antihypertensive Agents Introduction
11.2.4 Pfizer Revenue in Antihypertensive Agents Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Details
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Antihypertensive Agents Introduction
11.3.4 Sandoz Revenue in Antihypertensive Agents Business (2018-2024)
11.3.5 Sandoz Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Antihypertensive Agents Introduction
11.4.4 Teva Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.4.5 Teva Pharmaceuticals Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Antihypertensive Agents Introduction
11.5.4 Bayer Revenue in Antihypertensive Agents Business (2018-2024)
11.5.5 Bayer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antihypertensive Agents Introduction
11.6.4 Johnson & Johnson Revenue in Antihypertensive Agents Business (2018-2024)
11.6.5 Johnson & Johnson Recent Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Antihypertensive Agents Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Antihypertensive Agents Business (2018-2024)
11.7.5 Sun Pharmaceutical Industries Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Antihypertensive Agents Introduction
11.8.4 Merck Revenue in Antihypertensive Agents Business (2018-2024)
11.8.5 Merck Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Antihypertensive Agents Introduction
11.9.4 AstraZeneca Revenue in Antihypertensive Agents Business (2018-2024)
11.9.5 AstraZeneca Recent Developments
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Details
11.10.2 Daiichi Sankyo Business Overview
11.10.3 Daiichi Sankyo Antihypertensive Agents Introduction
11.10.4 Daiichi Sankyo Revenue in Antihypertensive Agents Business (2018-2024)
11.10.5 Daiichi Sankyo Recent Developments
11.11 Takeda
11.11.1 Takeda Company Details
11.11.2 Takeda Business Overview
11.11.3 Takeda Antihypertensive Agents Introduction
11.11.4 Takeda Revenue in Antihypertensive Agents Business (2018-2024)
11.11.5 Takeda Recent Developments
11.12 Actelion
11.12.1 Actelion Company Details
11.12.2 Actelion Business Overview
11.12.3 Actelion Antihypertensive Agents Introduction
11.12.4 Actelion Revenue in Antihypertensive Agents Business (2018-2024)
11.12.5 Actelion Recent Developments
11.13 Viatris
11.13.1 Viatris Company Details
11.13.2 Viatris Business Overview
11.13.3 Viatris Antihypertensive Agents Introduction
11.13.4 Viatris Revenue in Antihypertensive Agents Business (2018-2024)
11.13.5 Viatris Recent Developments
11.14 United Therapeutics
11.14.1 United Therapeutics Company Details
11.14.2 United Therapeutics Business Overview
11.14.3 United Therapeutics Antihypertensive Agents Introduction
11.14.4 United Therapeutics Revenue in Antihypertensive Agents Business (2018-2024)
11.14.5 United Therapeutics Recent Developments
11.15 Lupin Limited
11.15.1 Lupin Limited Company Details
11.15.2 Lupin Limited Business Overview
11.15.3 Lupin Limited Antihypertensive Agents Introduction
11.15.4 Lupin Limited Revenue in Antihypertensive Agents Business (2018-2024)
11.15.5 Lupin Limited Recent Developments
11.16 Hikma Pharmaceuticals
11.16.1 Hikma Pharmaceuticals Company Details
11.16.2 Hikma Pharmaceuticals Business Overview
11.16.3 Hikma Pharmaceuticals Antihypertensive Agents Introduction
11.16.4 Hikma Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.16.5 Hikma Pharmaceuticals Recent Developments
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Company Details
11.17.2 Aurobindo Pharma Business Overview
11.17.3 Aurobindo Pharma Antihypertensive Agents Introduction
11.17.4 Aurobindo Pharma Revenue in Antihypertensive Agents Business (2018-2024)
11.17.5 Aurobindo Pharma Recent Developments
11.18 Camber Pharmaceutical
11.18.1 Camber Pharmaceutical Company Details
11.18.2 Camber Pharmaceutical Business Overview
11.18.3 Camber Pharmaceutical Antihypertensive Agents Introduction
11.18.4 Camber Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024)
11.18.5 Camber Pharmaceutical Recent Developments
11.19 Major Pharmaceuticals
11.19.1 Major Pharmaceuticals Company Details
11.19.2 Major Pharmaceuticals Business Overview
11.19.3 Major Pharmaceuticals Antihypertensive Agents Introduction
11.19.4 Major Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.19.5 Major Pharmaceuticals Recent Developments
11.20 Glenmark Pharmaceuticals
11.20.1 Glenmark Pharmaceuticals Company Details
11.20.2 Glenmark Pharmaceuticals Business Overview
11.20.3 Glenmark Pharmaceuticals Antihypertensive Agents Introduction
11.20.4 Glenmark Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.20.5 Glenmark Pharmaceuticals Recent Developments
11.21 Zydus Pharmaceuticals
11.21.1 Zydus Pharmaceuticals Company Details
11.21.2 Zydus Pharmaceuticals Business Overview
11.21.3 Zydus Pharmaceuticals Antihypertensive Agents Introduction
11.21.4 Zydus Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.21.5 Zydus Pharmaceuticals Recent Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Details
11.22.2 Amneal Pharmaceuticals Business Overview
11.22.3 Amneal Pharmaceuticals Antihypertensive Agents Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024)
11.22.5 Amneal Pharmaceuticals Recent Developments
11.23 Endo International
11.23.1 Endo International Company Details
11.23.2 Endo International Business Overview
11.23.3 Endo International Antihypertensive Agents Introduction
11.23.4 Endo International Revenue in Antihypertensive Agents Business (2018-2024)
11.23.5 Endo International Recent Developments
11.24 Unichem Laboratories
11.24.1 Unichem Laboratories Company Details
11.24.2 Unichem Laboratories Business Overview
11.24.3 Unichem Laboratories Antihypertensive Agents Introduction
11.24.4 Unichem Laboratories Revenue in Antihypertensive Agents Business (2018-2024)
11.24.5 Unichem Laboratories Recent Developments
11.25 Huahai Pharmaceutical
11.25.1 Huahai Pharmaceutical Company Details
11.25.2 Huahai Pharmaceutical Business Overview
11.25.3 Huahai Pharmaceutical Antihypertensive Agents Introduction
11.25.4 Huahai Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024)
11.25.5 Huahai Pharmaceutical Recent Developments
11.26 Shijiazhuang Pharma Group
11.26.1 Shijiazhuang Pharma Group Company Details
11.26.2 Shijiazhuang Pharma Group Business Overview
11.26.3 Shijiazhuang Pharma Group Antihypertensive Agents Introduction
11.26.4 Shijiazhuang Pharma Group Revenue in Antihypertensive Agents Business (2018-2024)
11.26.5 Shijiazhuang Pharma Group Recent Developments
11.27 Shanghai Shyndec Pharmaceutical
11.27.1 Shanghai Shyndec Pharmaceutical Company Details
11.27.2 Shanghai Shyndec Pharmaceutical Business Overview
11.27.3 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Introduction
11.27.4 Shanghai Shyndec Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024)
11.27.5 Shanghai Shyndec Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antihypertensive Agents Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Thiazide Diuretics
Table 3. Key Players of Calcium Channel Blockers (CCB)
Table 4. Key Players of ACE Inhibitors
Table 5. Key Players of Angiotensin II Receptor Antagonists (ARBs)
Table 6. Global Antihypertensive Agents Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Antihypertensive Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Antihypertensive Agents Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Antihypertensive Agents Market Share by Region (2018-2024)
Table 10. Global Antihypertensive Agents Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Antihypertensive Agents Market Share by Region (2024-2034)
Table 12. Antihypertensive Agents Market Trends
Table 13. Antihypertensive Agents Market Drivers
Table 14. Antihypertensive Agents Market Challenges
Table 15. Antihypertensive Agents Market Restraints
Table 16. Global Antihypertensive Agents Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Antihypertensive Agents Revenue Share by Players (2018-2024)
Table 18. Global Top Antihypertensive Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive Agents as of 2022)
Table 19. Global Antihypertensive Agents Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Antihypertensive Agents Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Antihypertensive Agents, Headquarters and Area Served
Table 22. Global Key Players of Antihypertensive Agents, Product and Application
Table 23. Global Key Players of Antihypertensive Agents, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Antihypertensive Agents Revenue Market Share by Type (2018-2024)
Table 27. Global Antihypertensive Agents Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Antihypertensive Agents Revenue Market Share by Type (2024-2034)
Table 29. Global Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Antihypertensive Agents Revenue Share by Application (2018-2024)
Table 31. Global Antihypertensive Agents Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Antihypertensive Agents Revenue Share by Application (2024-2034)
Table 33. North America Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Antihypertensive Agents Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Antihypertensive Agents Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Antihypertensive Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Antihypertensive Agents Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Antihypertensive Agents Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Antihypertensive Agents Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Antihypertensive Agents Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Antihypertensive Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Antihypertensive Agents Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Antihypertensive Agents Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Antihypertensive Agents Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Antihypertensive Agents Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Antihypertensive Agents Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Antihypertensive Agents Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Antihypertensive Agents Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Antihypertensive Agents Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Antihypertensive Agents Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Antihypertensive Agents Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Antihypertensive Agents Market Size by Country (2024-2034) & (US$ Million)
Table 65. Baxter International Company Details
Table 66. Baxter International Business Overview
Table 67. Baxter International Antihypertensive Agents Product
Table 68. Baxter International Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 69. Baxter International Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Antihypertensive Agents Product
Table 73. Pfizer Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Sandoz Company Details
Table 76. Sandoz Business Overview
Table 77. Sandoz Antihypertensive Agents Product
Table 78. Sandoz Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 79. Sandoz Recent Developments
Table 80. Teva Pharmaceuticals Company Details
Table 81. Teva Pharmaceuticals Business Overview
Table 82. Teva Pharmaceuticals Antihypertensive Agents Product
Table 83. Teva Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 84. Teva Pharmaceuticals Recent Developments
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Antihypertensive Agents Product
Table 88. Bayer Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 89. Bayer Recent Developments
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Antihypertensive Agents Product
Table 93. Johnson & Johnson Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 94. Johnson & Johnson Recent Developments
Table 95. Sun Pharmaceutical Industries Company Details
Table 96. Sun Pharmaceutical Industries Business Overview
Table 97. Sun Pharmaceutical Industries Antihypertensive Agents Product
Table 98. Sun Pharmaceutical Industries Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 99. Sun Pharmaceutical Industries Recent Developments
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Antihypertensive Agents Product
Table 103. Merck Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 104. Merck Recent Developments
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Antihypertensive Agents Product
Table 108. AstraZeneca Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 109. AstraZeneca Recent Developments
Table 110. Daiichi Sankyo Company Details
Table 111. Daiichi Sankyo Business Overview
Table 112. Daiichi Sankyo Antihypertensive Agents Product
Table 113. Daiichi Sankyo Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 114. Daiichi Sankyo Recent Developments
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Antihypertensive Agents Product
Table 118. Takeda Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 119. Takeda Recent Developments
Table 120. Actelion Company Details
Table 121. Actelion Business Overview
Table 122. Actelion Antihypertensive Agents Product
Table 123. Actelion Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 124. Actelion Recent Developments
Table 125. Viatris Company Details
Table 126. Viatris Business Overview
Table 127. Viatris Antihypertensive Agents Product
Table 128. Viatris Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 129. Viatris Recent Developments
Table 130. United Therapeutics Company Details
Table 131. United Therapeutics Business Overview
Table 132. United Therapeutics Antihypertensive Agents Product
Table 133. United Therapeutics Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 134. United Therapeutics Recent Developments
Table 135. Lupin Limited Company Details
Table 136. Lupin Limited Business Overview
Table 137. Lupin Limited Antihypertensive Agents Product
Table 138. Lupin Limited Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 139. Lupin Limited Recent Developments
Table 140. Hikma Pharmaceuticals Company Details
Table 141. Hikma Pharmaceuticals Business Overview
Table 142. Hikma Pharmaceuticals Antihypertensive Agents Product
Table 143. Hikma Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 144. Hikma Pharmaceuticals Recent Developments
Table 145. Aurobindo Pharma Company Details
Table 146. Aurobindo Pharma Business Overview
Table 147. Aurobindo Pharma Antihypertensive Agents Product
Table 148. Aurobindo Pharma Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 149. Aurobindo Pharma Recent Developments
Table 150. Camber Pharmaceutical Company Details
Table 151. Camber Pharmaceutical Business Overview
Table 152. Camber Pharmaceutical Antihypertensive Agents Product
Table 153. Camber Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 154. Camber Pharmaceutical Recent Developments
Table 155. Major Pharmaceuticals Company Details
Table 156. Major Pharmaceuticals Business Overview
Table 157. Major Pharmaceuticals Antihypertensive Agents Product
Table 158. Major Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 159. Major Pharmaceuticals Recent Developments
Table 160. Glenmark Pharmaceuticals Company Details
Table 161. Glenmark Pharmaceuticals Business Overview
Table 162. Glenmark Pharmaceuticals Antihypertensive Agents Product
Table 163. Glenmark Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 164. Glenmark Pharmaceuticals Recent Developments
Table 165. Zydus Pharmaceuticals Company Details
Table 166. Zydus Pharmaceuticals Business Overview
Table 167. Zydus Pharmaceuticals Antihypertensive Agents Product
Table 168. Zydus Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 169. Zydus Pharmaceuticals Recent Developments
Table 170. Amneal Pharmaceuticals Company Details
Table 171. Amneal Pharmaceuticals Business Overview
Table 172. Amneal Pharmaceuticals Antihypertensive Agents Product
Table 173. Amneal Pharmaceuticals Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 174. Amneal Pharmaceuticals Recent Developments
Table 175. Endo International Company Details
Table 176. Endo International Business Overview
Table 177. Endo International Antihypertensive Agents Product
Table 178. Endo International Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 179. Endo International Recent Developments
Table 180. Unichem Laboratories Company Details
Table 181. Unichem Laboratories Business Overview
Table 182. Unichem Laboratories Antihypertensive Agents Product
Table 183. Unichem Laboratories Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 184. Unichem Laboratories Recent Developments
Table 185. Huahai Pharmaceutical Company Details
Table 186. Huahai Pharmaceutical Business Overview
Table 187. Huahai Pharmaceutical Antihypertensive Agents Product
Table 188. Huahai Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 189. Huahai Pharmaceutical Recent Developments
Table 190. Shijiazhuang Pharma Group Company Details
Table 191. Shijiazhuang Pharma Group Business Overview
Table 192. Shijiazhuang Pharma Group Antihypertensive Agents Product
Table 193. Shijiazhuang Pharma Group Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 194. Shijiazhuang Pharma Group Recent Developments
Table 195. Shanghai Shyndec Pharmaceutical Company Details
Table 196. Shanghai Shyndec Pharmaceutical Business Overview
Table 197. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Product
Table 198. Shanghai Shyndec Pharmaceutical Revenue in Antihypertensive Agents Business (2018-2024) & (US$ Million)
Table 199. Shanghai Shyndec Pharmaceutical Recent Developments
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antihypertensive Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Antihypertensive Agents Market Share by Type: 2022 VS 2034
Figure 3. Thiazide Diuretics Features
Figure 4. Calcium Channel Blockers (CCB) Features
Figure 5. ACE Inhibitors Features
Figure 6. Angiotensin II Receptor Antagonists (ARBs) Features
Figure 7. Global Antihypertensive Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Antihypertensive Agents Market Share by Application: 2022 VS 2034
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Antihypertensive Agents Report Years Considered
Figure 12. Global Antihypertensive Agents Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Antihypertensive Agents Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Antihypertensive Agents Market Share by Region: 2022 VS 2034
Figure 15. Global Antihypertensive Agents Market Share by Players in 2022
Figure 16. Global Top Antihypertensive Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive Agents as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antihypertensive Agents Revenue in 2022
Figure 18. North America Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Antihypertensive Agents Market Share by Type (2018-2034)
Figure 20. North America Antihypertensive Agents Market Share by Application (2018-2034)
Figure 21. North America Antihypertensive Agents Market Share by Country (2018-2034)
Figure 22. United States Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Antihypertensive Agents Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Antihypertensive Agents Market Share by Type (2018-2034)
Figure 26. Europe Antihypertensive Agents Market Share by Application (2018-2034)
Figure 27. Europe Antihypertensive Agents Market Share by Country (2018-2034)
Figure 28. Germany Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Antihypertensive Agents Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Antihypertensive Agents Market Share by Type (2018-2034)
Figure 36. China Antihypertensive Agents Market Share by Application (2018-2034)
Figure 37. Asia Antihypertensive Agents Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Antihypertensive Agents Market Share by Type (2018-2034)
Figure 39. Asia Antihypertensive Agents Market Share by Application (2018-2034)
Figure 40. Asia Antihypertensive Agents Market Share by Region (2018-2034)
Figure 41. Japan Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Antihypertensive Agents Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Antihypertensive Agents Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Antihypertensive Agents Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Antihypertensive Agents Market Share by Country (2018-2034)
Figure 51. Brazil Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Antihypertensive Agents Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Baxter International Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 58. Pfizer Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 59. Sandoz Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 61. Bayer Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 62. Johnson & Johnson Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 64. Merck Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 65. AstraZeneca Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 66. Daiichi Sankyo Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 67. Takeda Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 68. Actelion Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 69. Viatris Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 70. United Therapeutics Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 71. Lupin Limited Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 72. Hikma Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 73. Aurobindo Pharma Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 74. Camber Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 75. Major Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 76. Glenmark Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 77. Zydus Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 78. Amneal Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 79. Endo International Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 80. Unichem Laboratories Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 81. Huahai Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 82. Shijiazhuang Pharma Group Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 83. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2018-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed